Zacks restated their hold rating on shares of Globus Medical (NASDAQ:GMED) in a report released on Friday. Zacks’ analyst wrote, “Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders.